Federal Drug Control: The Evolution of Policy and Practice

Erlen, Jonathon

ISBN 10: 0789018926 / ISBN 13: 9780789018922

Editore: CRC Press, 2004

Riguardo questo articolo

Most items will be dispatched the same or the next working day. A copy that has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.

Codice articolo wbs3931881514

Dati bibliografici

• Titolo: Federal Drug Control: The Evolution of Policy and Practice
• Editore: CRC Press
• Data di pubblicazione: 2004
• Lingua: Inglese
• ISBN 10: 0789018926
• ISBN 13: 9780789018922
• Rilegatura: Brossura
• Condizione: Very Good
• Peso: 390 grammi

Descrizione articolo

Riassunto

A comprehensive look at the beginnings of the current drug problems in the United States

Federal Drug Control: The Evolution of Policy and Practice presents an overview of the key issues and key individuals responsible for the creation of the federal government’s efforts to control illegal drugs in the United States, from 1875-2001. The book focuses special attention on federal legislation that constructed the federal drug regulatory machinery and the Supreme Court cases that interpreted these laws and their implementation. An esteemed panel of scholars, including co-editor Joseph Spillane, author of Cocaine: From Medical Marvel to Modern Menace, and William B. McAllister, author of Drug Diplomacy in the Twentieth Century: An International History, traces the internal tensions between factions favoring medicalization and criminalization throughout the 20th century, examining the difficult choices that continue to be made in this ongoing debate.

The central question in the government’s response to the crisis of illicit drugs in the United States has remained the same for more than 125 years: Should the government rely on educational and treatment programs or turn to the criminal justice system for answers? Federal Drug Control examines the historic turning points of the debate, including the 19th Century origins of the controversy, legislation and subsequent Supreme Court decisions in the 20th Century, international attempts at drug control agreements, and the emergence of new illicit drugs. The book also looks at the influential figures of the debate, including Levi Nutt, Lawrence Kolb, Richard Pearson Hobson, A.G. DuMez, and Harry J. Anslinger who ran the Federal Bureau of Narcotics (FBN) for more than 30 years.

Federal Drug Control examines:

• the history of cocaine use in the 20th Century
• the history of marijuana use in the 20th Century
• the advent of psychotropic drugs in the 1960s
• the origins of the Harrison Narcotic Act
• the federal government’s efforts to limit the pharmacy profession’s control over prescription drugs
• and much more!

Federal Drug Control: The Evolution of Policy and Practice is an essential resource for criminologists, historians, social historians, sociologists, anthropologists, public policymakers, academics, and anyone interested in the broad issues involved in how the federal government deals with the problem of illicit drugs in the United States.

Contenuti

• About the Editors
  
• Contributors
  
• Foreword
  
• Preface
  
• Chapter 1. The Road to the Harrison Narcotics Act: Drugs and Their Control, 1875-1918
  
• Drugs and Drug Distribution in Late Nineteenth-Century America
  
• Defining the Boundaries of Legitimacy
  
• Early Drug Legislation
  
• The Role of the Federal Government
  
• Great Expectations and Unanswered Questions
  
• Chapter 2. Building a Drug Control Regime, 1919-1930
  
• Charting an Official Policy
  
• The Retreat of the Treatment and Maintenance Models
  
• Official Control of Information
  
• Drugs, the Courts, and the Federal Criminal Law
  
• Law Enforcement in Practice
  
• Cops and Doctors
  
• Penetrating the Marketplace
  
• Corruption
  
• Drug Agents and Routine Activities
  
• Chapter 3. Under the Influence: Harry Anslinger’s Role in Shaping America’s Drug Policy
  
• The Marihuana Tax Act of 1937 (MTA)
  
• The Boggs Act of 1951
  
• Chapter 4. The Narcotic Control Act Triggers the Great Nondebate: Treatment Loses to Punishment
  
• Beyond Boggs: The Narcotic Control Act of 1956
  
• Let the Debate Begin?
  
• FBN Comments on Narcotic Drugs, or the FBN Attacks the Interim Report
  
• 1959 NBC Monitor—Still No Discussion
  
• Legacy of the ABA-AMA Joint Committee
  
• Conclusion
  
• Chapter 5. The FDA and the Practice of Pharmacy: Prescription Drug Regulation Before 1968
  
• Pharmacists, Physicians, and Early Prescribing and Dispensing Practices
  
• Prescriptions and Adequate Directions for Safe Use
  
• Dangerous Drugs and the Regulation of Barbiturates and Amphetamines
  
• Conclusion: Legislative Answers to Prescription Drugs and Dangerous Drugs
  
• Chapter 6. Habitual Problems: The United States and International Drug Control
  
• Introduction
  
• 1880 to 1920: Defining the Issues
  
• Early 1920x to Mid-1930s: Shaping the International Control Regime
  
• Mid-1930s to Mid-1960s: Implementing the Rules
  
• Late 1960s to 2000: Brave New World
  
• Conclusion
  
• Appendix: Multilateral Treaties on Narcotics and Psychotropic Substances
  
• Chapter 7. Federal Policy in the Post-Anslinger Era: A Guide to Sources, 1962-2001
  
• Seeds of Change
  
• The Psychoactive Revolution
  
• The Nixon Administration
  
• International Drug Enforcement
  
• Marijuana
  
• Cocaine and Drug War Escalation
  
• Index
  
• Reference Notes Included